The US market for neurovascular devices will grow strongly through 2027 as a result of the adoption of innovative devices as well as the ongoing expansion of dedicated infrastructure for neurovascular interventions. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for stroke devices in the US across a 10-year period


The results of the ASTER trial triggered the incorporation of aspiration thrombectomy into guidelines as a first-line treatment for AIS.

How will the updated guidelines impact market growth?

What barriers continue to affect uptake of aspiration thrombectomy?

How significantly are cost concerns impacting neurovascular thrombectomy device choice in the US market?

A number of companies are launching new neurovascular devices in the US market.

How strongly will competition increase in market segments that were previously monopolized by a single competitor? 

What tactics are smaller companies using to gain share in the market?

How does the competitive landscape in the US differ from other global neurovascular device markets?

The initial results of the HEAT trial demonstrated the superiority of hydrogel-coated embolization coils in comparison to bare platinum coils.

How dramatically will these results impact the use of coated and bare platinum coils? What role will cost play in device uptake?

Which companies will benefit from these favorable results, and which companies will be negatively impacted?

Table of contents

  • United States
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • Neurovascular Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
        • Physician Training and Marketing
        • Pricing Strategies and Purchasing Options
      • Market Developments
    • Neurovascular Thrombectomy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
        • Physician Training and Marketing
        • Pricing Strategies and Purchasing Options
    • Neurovascular Embolization Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
        • Physician Training and Marketing
    • Neurovascular Angioplasty Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Neurovascular Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Yang Yun Li, PhD

Yang Yun Li is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in clot management device markets. Yang holds a in Pharmaceutical Sciences from the University of Toronto.


Related Reports

Aortic Repair Devices | Medtech 360 | Market Insights | Latin America (Supplemental)

The Latin American market for aortic repair devices will expand at a moderate rate through 2027, driven primarily by endovascular procedure volume growth and the continued developme...

View Details

Vascular Closure Devices | Medtech 360 | Market Insights | Global

The global VCD market will grow modestly through 2027 as a result of increasing endovascular interventional procedural volumes, and increasing clinic...

View Details

Structural Heart Closure Devices | Medtech 360 | Market Insights | Global

The global market for structural heart closure devices will grow rapidly in most countries covered through 2028, driven by strong clinical data, the availability of reimbursement, a...

View Details

Transcatheter Embolization and Occlusion Devices | Medtech 360 | Market Insights | Japan

Japan's aging population will drive steady growth in TEO procedure volumes through 2028, supporting TEO device market expansion, although revenue growth will continue to be hindered by...

View Details